ImmunoGen Q2 2021 Earnings Preview
- ImmunoGen (NASDAQ:IMGN) is scheduled to announce Q2 earnings results on Friday, July 30th, before market open.
- The consensus EPS Estimate is -$0.18 and the consensus Revenue Estimate is $18.92M (+25.9% Y/Y).
- Over the last 3 months, EPS estimates have seen…
